41 related articles for article (PubMed ID: 448075)
1. Anti-factor H antibody-positive C3 glomerulonephritis secondary to poststreptococcal acute glomerulonephritis with diabetic nephropathy.
Oba Y; Mizuno H; Taneda S; Sawai T; Oda T; Ikuma D; Yamanouchi M; Suwabe T; Kono K; Kinowaki K; Ohashi K; Sawa N; Ubara Y
CEN Case Rep; 2024 Apr; 13(2):110-116. PubMed ID: 37452997
[TBL] [Abstract][Full Text] [Related]
2. Modeling C3 glomerulopathies: C3 convertase regulation on an extracellular matrix surface.
Pisarenka S; Meyer NC; Xiao X; Goodfellow R; Nester CM; Zhang Y; Smith RJH
Front Immunol; 2022; 13():1073802. PubMed ID: 36846022
[TBL] [Abstract][Full Text] [Related]
3. C3 concentrations can be normal in patients with C3 glomerulopathy secondary to C3 nephritic factor.
Anderson H; Van Voorthuizen M; O'Donnell J; Beck S
J Clin Pathol; 2024 Mar; ():. PubMed ID: 38538072
[TBL] [Abstract][Full Text] [Related]
4. A Nef Precursor or Benign Counterpart: High Prevalence of Healthy Subjects with Antibody Reactivity to the C3-Convertase.
Culek CT; Nester CM
Kidney360; 2023 Nov; 4(11):1615-1622. PubMed ID: 37907434
[TBL] [Abstract][Full Text] [Related]
5. Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.
Doekes G; Vanes LA; Daha MR
Immunology; 1982 Apr; 45(4):705-13. PubMed ID: 7068172
[TBL] [Abstract][Full Text] [Related]
6. C3 nephritic factor and hypocomplementaemia in a clinically healthy individual.
Gewurz AT; Imherr SM; Strauss S; Gewurz H; Mold C
Clin Exp Immunol; 1983 Oct; 54(1):253-8. PubMed ID: 6616970
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity, polypeptide chain composition and antigenic reactivity of autoantibodies (F-42) that are directed against the classical pathway C3 convertase of complement and isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; van Es LA
Clin Exp Immunol; 1984 Jun; 56(3):614-20. PubMed ID: 6430610
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor.
Daha MR; Van Es LA
Immunology; 1981 May; 43(1):33-8. PubMed ID: 6166544
[TBL] [Abstract][Full Text] [Related]
9. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
[TBL] [Abstract][Full Text] [Related]
10. Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations.
Corvillo F; Okrój M; Nozal P; Melgosa M; Sánchez-Corral P; López-Trascasa M
Front Immunol; 2019; 10():886. PubMed ID: 31068950
[TBL] [Abstract][Full Text] [Related]
11. Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase.
Daha MR; van Es LA
J Immunol; 1979 Mar; 122(3):801-5. PubMed ID: 448075
[TBL] [Abstract][Full Text] [Related]
12. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
Sobel AT; Cooper NR; Schreiber RD
J Immunol; 1979 Jan; 122(1):34-8. PubMed ID: 762421
[TBL] [Abstract][Full Text] [Related]
13. Further evidence for the antibody nature of C3 nephritic factor (C3NeF).
Daha MR; van Es LA
J Immunol; 1979 Aug; 123(2):755-8. PubMed ID: 379217
[TBL] [Abstract][Full Text] [Related]
14. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
15. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.
Ng YC; Peters DK
Clin Exp Immunol; 1986 Aug; 65(2):450-7. PubMed ID: 3641695
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
